Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen research firms that are presently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The […]
20 Oct 06:52 · The Markets Daily